1800 202 8726
PET-CT false negatives

Cancers That Do Not Show — on PET-CT

A clear PET-CT scan does not always mean the cancer is absent. Some tumour types use very little glucose — and glucose uptake is exactly what PET-CT measures. For those cancers, a different scan gives more reliable information.

Medically reviewed by Dr. T. Raghavender Reddy, Medical Oncologist, MBBS · DM (Medical Oncology) · MD (Radiation Oncology) · Last reviewed September 2026

  • Some cancers are PET-negative — They use little glucose, so the tracer does not accumulate in them even when the disease is active.
  • A clear scan is not always reassuring — For certain cancer types, a normal PET-CT has limited diagnostic meaning without a supporting scan.
  • Better tools exist — Each PET-negative cancer type has a preferred alternative — PSMA PET, DOTATATE PET, MRI, or radioiodine scan.
  • Tissue diagnosis is still required — No imaging, including PET-CT, replaces a biopsy. Imaging shows where; pathology says what.
4.8 · 800+ Google reviews · 15,000+ patients treated
Limited Slots Today

Talk to a medical oncologist

₹950   Today: FREE  ·  Including free written second opinion

Reply within 2 working hours
Report reviewed by a senior oncologist
Confidential. No commitment to start treatment.
or
Call 1800 202 8726
17+
Cancer Specialists
on Panel
96.9%
Breast Cancer
Survival Rate*
15,000+
Patients
Treated
4.8★
Google Rating
(800+ reviews)

Several cancer types do not appear reliably on PET-CT, even when active. These cancers use very little glucose — which is what PET-CT detects. Prostate cancer, well-differentiated neuroendocrine tumours, certain indolent lymphomas, renal cell carcinoma, and well-differentiated thyroid cancers are the most important examples. Each has a preferred alternative scan.

CION does PET-CT in Hyderabad from Rs 10,499 — among the lowest published prices in the city, with no hidden charges. Indicative price, as of September 2026.

Why do some cancers not show up on PET-CT?

PET-CT works by injecting a radioactive glucose tracer into your body and imaging where it collects. Cancer cells that are growing quickly absorb large amounts of glucose, which makes them visible.

Cancers that grow slowly, or that have a particular cell structure, use very little glucose. The tracer does not accumulate in them, so they do not appear — even when the tumour is present and active.

This is a known limitation of the technology, not a scanning error. Your oncologist selects the imaging method based on your specific cancer type, which is why different patients receive different scans.

Which cancers are commonly not visible on PET-CT?

  • Prostate cancerEspecially low-grade and early-stage disease. The PSMA PET scan is now the preferred tool for staging and restaging, recommended by NCCN and ESMO over standard FDG PET-CT.
  • Well-differentiated neuroendocrine tumours (carcinoid tumours)Grade 1 and grade 2 NETs have very low glucose uptake. A Ga-68 DOTATATE PET scan is used instead, and is the standard recommended by ENETS and NCCN.
  • Low-grade indolent lymphomasFollicular lymphoma, MALT lymphoma, and marginal zone lymphoma are often poorly visible. Aggressive subtypes such as Hodgkin disease and DLBCL are usually PET-avid.
  • Renal cell carcinoma (kidney cancer)Glucose is excreted through the kidneys, creating high background signal that obscures tumour uptake. Contrast-enhanced CT or MRI is the standard approach.
  • Well-differentiated thyroid cancerPapillary and follicular thyroid cancers usually absorb radioiodine rather than glucose. Radioiodine scans and thyroglobulin blood levels are the preferred monitoring tools.
  • Lobular breast cancerThis subtype is less FDG-avid than ductal breast cancer. MRI is more sensitive for lobular disease and is preferred for staging.
  • Mucinous tumoursSome colorectal and ovarian cancers with high mucin content appear less clearly on PET. CT or MRI is used to assess size and spread.
  • Low-grade brain tumoursThe brain uses large amounts of glucose normally, making it difficult to distinguish tumour from healthy brain tissue. MRI is the primary imaging tool for all brain tumours.

Not sure what this means for you?

Share your reports and a senior oncologist will explain your options in plain language — no obligation to start treatment.

PET-CT Partner Centres

PET-CT Scan Centres in Hyderabad

CION offers PET-CT scans through 4 trusted partner PET-CT centres across Hyderabad, so you can choose the one closest to you. Call 18002028726 and we’ll guide you to the earliest available appointment.

These are partner diagnostic centres within the CION network. Toll-free booking: 18002028726.

Meet the Specialists

17+ senior cancer specialists. One panel for your case.

Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.

Dr. Naresh Gundu
Medical Oncologist

Dr. Naresh Gundu

MBBS, DNB (Internal Medicine), DM (Medical Oncology)

View Profile
Dr. C. Raghavendra Reddy
Medical Oncologist

Dr. C. Raghavendra Reddy

MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)

View Profile
Dr. Bharati Devi Gorantla
Medical Oncologist

Dr. Bharati Devi Gorantla

MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)

View Profile
Dr. Owais Mohammed
Medical Oncologist

Dr. Owais Mohammed

MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)

View Profile
Dr. T. Raghavender Reddy
Medical Oncologist

Dr. T. Raghavender Reddy

MBBS, DM (Medical Oncology), MD (Radiation Oncology)

View Profile
Dr. N. Kiranmayee
Medical Oncologist

Dr. N. Kiranmayee

MBBS, DM (Medical Oncology), MD (Internal Medicine)

View Profile
Dr. Muralidhar Muddusetty
Surgical Oncologist

Dr. Muralidhar Muddusetty

MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)

View Profile
Dr. Raghavendra Naik
Surgical Oncologist

Dr. Raghavendra Naik

MBBS, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Mohammed  Imaduddin
Surgical Oncologist

Dr. Mohammed Imaduddin

M.B.B.S, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Vinay Mamidala
Surgical Oncologist

Dr. Vinay Mamidala

MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)

View Profile
Dr. Paila Gowri Naidu
Surgical Oncologist

Dr. Paila Gowri Naidu

MBBS, MS (General Surgery), M.Ch (Surgical Oncology), FMAS

View Profile
Dr. Venkata Sushma P
Radiation Oncologist

Dr. Venkata Sushma P

MBBS, MD (Radiation Oncology)

View Profile
Dr. Kirti Ranjan Mohanty
Radiation Oncologist

Dr. Kirti Ranjan Mohanty

MBBS, MD (Radiation Oncology)

View Profile
Dr. Gangadhar Vajrala
Radiation Oncologist

Dr. Gangadhar Vajrala

MBBS, MD (Radiation Oncology), MPH

View Profile
Dr. Basudev Pokhrel
Hematologist

Dr. Basudev Pokhrel

MBBS, M.D (Immunohematology & Blood Transfusion)

View Profile
Dr. Mohammed Imran
Interventional Radiologist

Dr. Mohammed Imran

View Profile
Dr. Vajja Sandeep Kumar
Surgical Oncologist

Dr. Vajja Sandeep Kumar

MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology

View Profile
Dr. Sridhar Kamani
Surgical Oncologist

Dr. Sridhar Kamani

MBBS, MS (General Surgery), DrNB (Surgical Oncology)

View Profile

Want a specific doctor for your case? Mention them when booking.

Book Free Consultation

You do not have to work this out alone

A 45-minute consultation with a specialist who treats this every week.

Book Free Consultation Call 1800 202 8726

What does a clear PET-CT mean when your cancer is PET-negative?

If you have one of these cancer types, a clear PET-CT does not confirm the cancer is absent or controlled. It confirms only that this scan did not detect what it is not designed to detect.

Your team will interpret your PET-CT result alongside the appropriate scan for your cancer type, your tumour marker levels, and your biopsy findings. No single test makes the whole picture.

If you have received a report that is confusing you, bring it to your next appointment and ask your oncologist to walk through it in the context of your specific diagnosis. Do not interpret a clear PET-CT as reassurance when your symptoms or other results say otherwise.

What is used instead for PET-negative cancers?

PSMA PET scan
A PET scan that uses a tracer targeting prostate-specific membrane antigen rather than glucose. It is significantly more sensitive for prostate cancer than standard FDG PET-CT, and is recommended by NCCN and ESMO for staging and restaging.
Ga-68 DOTATATE PET
A PET scan using a tracer that binds to receptors found on neuroendocrine tumour cells. It is the preferred staging and restaging tool for well-differentiated NETs according to ENETS and NCCN guidance.
Radioiodine scan
Used for differentiated thyroid cancers. Thyroid cells — including most differentiated thyroid cancer cells — absorb iodine. A radioactive form of iodine is given and then imaged with a gamma camera.
Contrast-enhanced MRI
Preferred for brain tumours, lobular breast cancer, liver lesions, and bone marrow assessment. It does not depend on glucose uptake and provides excellent soft-tissue detail.
Contrast-enhanced CT
Standard for kidney cancer staging and for following mucinous tumours. It provides precise anatomical information about the size and location of disease without relying on metabolic activity.
Tumour markers
Blood tests such as PSA for prostate cancer, thyroglobulin for thyroid cancer, and Chromogranin A for neuroendocrine tumours are used alongside imaging to track disease activity and treatment response.

CION does PET-CT in Hyderabad from Rs 10,499 — among the lowest published prices in the city — including an oncologist-reviewed report and a free Rs 950 consultation. Indicative price, as of September 2026.

Explore 94 more Understanding Your PET-CT Report topics

All Understanding Your PET-CT Report →

Your next step

Talk to an oncologist about your scan

Your PET-CT report read by a senior oncologist, explained in plain language, with a free 45-minute consultation.

Book Free Consultation Call 1800 202 8726
Common questions

Frequently asked questions

My PET-CT was clear but I still have symptoms. What should I do?

Tell your oncologist about your symptoms at your next appointment, or sooner if they are worsening. A clear PET-CT does not rule out active disease in PET-negative cancer types, and symptoms that persist are information your team needs regardless of what any scan shows. Your oncologist may order a different type of imaging or a tumour marker test better suited to your diagnosis. Do not interpret a clear PET-CT as confirmation that nothing is wrong when you still feel unwell.

Can prostate cancer show on a standard PET-CT at all?

Standard FDG PET-CT has poor sensitivity for prostate cancer, particularly when PSA is low or the disease is low-grade. The PSMA PET scan uses a prostate-specific tracer rather than glucose, and NCCN and ESMO guidance both recommend it over FDG PET-CT for prostate cancer staging and restaging. If you have prostate cancer and a PET scan is being considered, ask your oncologist specifically whether PSMA PET is available and appropriate for your situation.

My doctor ordered an MRI instead of a PET-CT. Does that mean the cancer is more serious?

No. The choice of scan is based on which imaging tool gives the most reliable information for your specific cancer type, not on how advanced the disease is. For brain tumours, lobular breast cancer, and certain liver cancers, MRI gives better information than PET-CT regardless of stage. An MRI being ordered instead of, or alongside, PET-CT is a sign your team is using the right tool for your diagnosis.

Is PSMA PET available at CION?

CION coordinates response-assessment and staging scans with partner imaging centres. Ask your oncologist at your next appointment whether PSMA PET is available through your centre's referral network and whether it is appropriate for your current stage and treatment plan. Availability varies by location, and your treating team will know which centres they work with and what wait times to expect.

Does 'well-differentiated' mean the cancer is not serious?

Well-differentiated means the cancer cells look more like normal cells under a microscope and tend to grow more slowly. In some cases this is associated with a better long-term outlook, but it is not a guarantee, and it does not mean the cancer can be left untreated. Well-differentiated neuroendocrine tumours and thyroid cancers, for example, can still spread and require active management. Your oncologist will explain what your tumour grade means specifically for your cancer type and stage.

What if my cancer type is usually PET-avid but my scan came back clear?

A clear PET-CT in a cancer type that is usually visible on PET — such as Hodgkin lymphoma or DLBCL — is meaningful information and is factored into treatment decisions. However, it is always interpreted alongside your clinical examination, symptoms, and other test results. If there is genuine uncertainty, your oncologist may recommend a biopsy of a previously involved site to confirm what the scan is showing. Never interpret any single scan result in isolation from the rest of your clinical picture.

Call now Book free consultation